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Abstract Neutrophil oxidative burst/degranulation activities were measured using CpG in vitro stim-
ulation. Neutrophils isolated from pigs 6 weeks of age were incubated with treatment for 1 hr at
39°C. Neutrophils had increased degranulation activity when treated with CpG when compared to
the activity of cells treated with non CpG. Neutrophils treated with CpG exhibited an increase in
oxidative burst. CpG resulted in levels of activity comparable to those observed with PMA stimula-
tion. Two of the swine CpG (p2006 and pD19) were chosen for administration to swine to observe
the effects on S. choleraesuis (SC) infection. Pigs were administered 1mg of CpG and subsequent-
ly challenged with SC. SC numbers in cecal contents in one CpG group were reduced by two to
three logs when compared to control numbers and other CpG groups. In addition, reductions in SC
positive rectal swabs, liver, spleen, jejunal, ileal, and colon colonization were observed.
Introduction The mammalian neutrophil is a first line of defense against invading pathogens and
represents an important part of the innate immune defenses. The immunostimulatory activities of
certain DNA antigens expressed by bacteria and other pathogens have been found to be linked to
the recognition of these antigens by host receptors in the Toll-like receptor (TLR) family of recep-
tors (Hemmi et al, 2000). Bacterial DNA has been found to be a potent immune stimulator and
this activity has been linked to the presence of a high frequency of unmethylated CpG dinu-
cleotides. CpG oligodeoxynucleotides (CpG-ODN) have been found to interact with TLR9 (Hemmi
et al, 2000; Bauer et al, 2001). This interaction leads to a cascade of intracellular signaling result-
ing in gene expression and the production of immunomodulatory molecules including cytokines,
helping to formulate aspects of both the innate and the adaptive host responses to invading
organisms (Freytag, Clements 2005). CpG-ODN could be used as adjuvants for vaccines to
increase their effectiveness as well as be used on their own as immune stimulators in domestic
food animals and in human medicine (Freytag, Clements 2005; Verfaillie et al, 2005). 
Salmonellae are known to colonize the gut of domestic swine and pose a risk for food born
disease in humans. In addition, multiple serotypes are known to cause disease in swine including
Salmonella choleraesuis, S. Typhimurium, and S. typhisuis, along with many others. Disease can
vary from enterocolitis, septicemia, pneumonia to meningitis/encephalitis and mortality. In
humans, food born disease from contaminated food products, including pork products, remains a
continuing public health concern.
The purpose of the present investigation was to compare the effects of CpG-ODN known to
stimulate immune responses in humans, pigs, and mice on neutrophils from swine in vitro and to
determine if the oral administration of CpG-ODN in weaned pigs would reduce gut colonization
and fecal excretion of S. choleraesuis in vivo.
Materials and Methods
Neutrophils were isolated from pigs (approx. 10kg body weight) using density gradient centrifugation.
CpG-ODN The following CpG-ODN and non-CpG containing control (n2041) (Biosource
International) were used for in vitro and in vivo (marked with “x”) assays:
pD19 G*G*T*G*C*A*T*C*G*A*T*G*C*A*G*G*G*G*G*G x
p2006 T*C*A*T*C*G*A*T*T*T*A*T*C*G*A*T*T*A*T*C*G*A*T x
n2041 C*T*G*G*T*C*T*T*T*C*T*G*G*T*T*T*T*T*T*T*C*T*G*G x
CpG#17 G*T*C*G*T*T*G*T*C*G*T*T*G*T*C*G*T*T
Degranulation assay Neutrophils (8x106 cells/ml) were incubated with respective stimulant for 1
hour at 39°C. Tubes were then transferred to an ice bath for 10 minutes. Tubes were centrifuged
at 250x g for 10min. at 4°C. Supernatants were then removed and stored at 4C. Each sample
supernatant (25µl) or appropriate standard was added to each well in a costar flat bottom elisa
plate #3915, non-treated, opaque and incubated with 50µl of freshly prepared substrate for 4h at
41°C in the dark. Stop solution was then added (200µl). Liberated 4-methylumbelliferone was
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measured fluorimetrically (excitation: 355nm, emission: 460nm) with a GENios Plus Fluorescence
Microplate Reader (Tecan US Inc.). Values were extrapolated from the standard curve.
Oxidative burst assay Production of ROS by swine neutrophils during oxidative burst was meas-
ured by the oxidation of DCFH-DA to fluorescent DCF. Neutrophils (1 ml at 8x106 cells/ml) were
incubated with stimulants and DCFH-DA (10µg/ml) for 1 h at room temperature. Aliquots (150µl)
were then placed into black 96-well plates and the fluorescence was measured using a GENios
Plus Fluorescence Microplate Reader (Tecan US Inc.) at 485 nm excitation and 530 emission
wavelengths. The fluorescent units were recorded (RFU).
In vivo S. choleraesuis study Twelve pigs, average weight 26kg, were randomly assigned to 1 of
4 groups. Pigs were orally administered the respective treatment or control (1mg/pig) in 2ml vol-
umes. Twenty four hours later, pigs were challenged by oral gavage with 109 colony-forming units
(cfu) of S. choleraesuis. Rectal swabs were obtained daily from each pig and pigs in all groups
were euthanized on day 7. At necropsy, tissues and contents from organs and the gut were cul-
tured for the presence of S. choleraesuis using standard isolation techniques.  
Results Results from in vivo culture of daily rectal swabs and tissue cultured for the presence of
S. choleraesuis are presented below.
< CFU determinations in cecal contents were as follows:
< 2041 – 3.4 x 103 CFU/g content
< p2006 – 3.5 x 103 CFU/g content
< pD19 – 10 CFU/g content
< SC control – 4.4 x 103 CFU/g content
Total # of positive samples/group in ICLN, Liver, spleen, jejunum, ileum, cecum, and colon combined:
< 2041 – 17/21
< p2006 – 15/21
< pD19 – 8/21
< SC control – 16/21
Total Number of daily rectal swabs positive for S. choleraesuis over 7 days:
< 2041 – 15/21
< p2006 – 17/21
< pD19 – 7/21
< SC control – 14/21
Results of the in vitro degranulation and oxidative burst assays are presented in Figures 1 and 2.
Discussion The use of CpG sequences as adjuvants or as direct immunostimulators presents a
novel tool for the reduction of pathogens in food animals as well as people. The induction of the
host’s endogenous immune mechanisms to fight infection and/or disease is also one way in
which food animal producers could reduce the use of antibiotics as prophylactic or growth pro-
moter measures, although a balance between growth potential of livestock and the energy costs
of host immune functions must be considered.  
In the present study, CpG DNA
(pD19) was found to reduce
Salmonella colonization in the gut and
organs of swine. In addition, neu-
trophils isolated from the peripheral
blood of pigs showed increased func-
tional characteristics in the presence
of CpG DNA (p2006, CpG 17, pD19)
sequences than those not exposed to
these sequences.  Studies in chickens
have also shown the effectiveness of
CpG DNA in protecting against
Salmonella infections and in stimulat-
ing the innate immune functions of
the avian host (He et al, 2005).
Although on their own, CpG
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sequences show promise in stimulating the host innate immune response, it is more likely that
they can be used optimally as adjuvants for current or new vaccines against diseases and food-
born pathogens.  
Conclusions CpG DNA (pD19) was found to be effective in increasing the function of porcine
neutrophils in vitro. In vivo, CpG DNA treatment of swine was found to reduce the shedding of
Salmonella as well as reduce the colonization of lymph nodes, spleen, liver and the gastrointesti-
nal tract of swine. Further study of the use of CpG sequences as adjuvants and as direct treat-
ments aimed at the reduction of food born pathogens in swine need to be conducted.  
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